Perspective Therapeutics, Inc. (CATX) Stock
AMEX · CATX
2.97
Fundamentals
Market cap
$328.76M
Price / Earnings ratio
-2.8x
Price / Sales ratio
803.9x
Price / Book ratio
1.0x
Return on assets
-0.3%
Ex-Dividend date
N/A
Last payment date
N/A
Dividend amount
$0.00
Dividend yield
0.0%
Debt / Equity ratio
N/A
Latest news
About Perspective Therapeutics, Inc.
No description available.
SectorHealthcare
IndustryMedical Devices
Employees163
CEOMr. Johan M. Spoor
IPO DateNov 10, 2005
HeadquartersSeattle, WA
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Johan M. Spoor | CEO & Director | 1972 |
| Mr. Joel David Sendek | CFO & Principal Financial Officer | 1967 |
| Dr. Markus Puhlmann M.B.A., M.D. | Chief Medical Officer | 1966 |
| Dr. Michael K. Schultz Ph.D. | Co-Founder & Senior Scientific Advisor | — |
| Mr. Shane Cobb | Executive Vice President of Operations | — |
| Mr. Jonathan R. Hunt | Chief Accounting Officer | 1967 |
| Dr. Paul Lyne Ph.D. | Chief Science Officer | — |
| Ms. Annie J. Cheng | Vice President of Investor Relations | 1976 |
| Mr. Chris Nenno | General Counsel & Corporate Secretary | — |
| Mr. Andrew Bright | Executive Vice President of Brachytherapy | — |
Fundamentals
Valuation
Market cap$328.76M
Price-to-sales ratio803.91
Price-to-book value1.02
Price-earnings ratio-2.80
Return on Equity-42.00%
Return on SalesN/A
Return on AssetsN/A
PEG ratioN/A
Earnings Per Share
Earnings Per Share$-1.33
Income Statement
Average volume1,696,468
EBITDA$-107.93M
1 year high (52w)$6.16
1 year low (52w)$1.96
Dividend
Ex dividend dateN/A
Dividend amount$0.00
Dividend yield0.00%
Last payment dateN/A
Dividend yield (TTM)N/A
Next earnings reportN/A
Solvency
Debt-to-equity ratioN/A



